Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Non-Current Assets (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Non-Current Assets readings, the most recent being $14.9 million for Q4 2021.

  • On a quarterly basis, Non-Current Assets fell 50.57% to $14.9 million in Q4 2021 year-over-year; TTM through Dec 2021 was $105.3 million, a 13.0% decrease, with the full-year FY2021 number at $14.9 million, down 50.57% from a year prior.
  • Non-Current Assets hit $14.9 million in Q4 2021 for Minerva Neurosciences, down from $30.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $30.4 million in Q4 2019 to a low of $14.9 million in Q4 2021.
  • Median Non-Current Assets over the past 3 years was $30.2 million (2020), compared with a mean of $28.5 million.
  • The widest YoY moves for Non-Current Assets: up 0.36% in 2021, down 50.57% in 2021.
  • Minerva Neurosciences' Non-Current Assets stood at $30.4 million in 2019, then decreased by 0.58% to $30.2 million in 2020, then crashed by 50.57% to $14.9 million in 2021.
  • The last three reported values for Non-Current Assets were $14.9 million (Q4 2021), $30.1 million (Q3 2021), and $30.1 million (Q2 2021) per Business Quant data.